Protein Phosphatase 2A Improves Cardiac Functional Response to Ischemia and Sepsis

Int J Mol Sci. 2022 Apr 23;23(9):4688. doi: 10.3390/ijms23094688.

Abstract

Reversible protein phosphorylation is a posttranslational modification of regulatory proteins involved in cardiac signaling pathways. Here, we focus on the role of protein phosphatase 2A (PP2A) for cardiac gene expression and stress response using a transgenic mouse model with cardiac myocyte-specific overexpression of the catalytic subunit of PP2A (PP2A-TG). Gene and protein expression were assessed under basal conditions by gene chip analysis and Western blotting. Some cardiac genes related to the cell metabolism and to protein phosphorylation such as kinases and phosphatases were altered in PP2A-TG compared to wild type mice (WT). As cardiac stressors, a lipopolysaccharide (LPS)-induced sepsis in vivo and a global cardiac ischemia in vitro (stop-flow isolated perfused heart model) were examined. Whereas the basal cardiac function was reduced in PP2A-TG as studied by echocardiography or as studied in the isolated work-performing heart, the acute LPS- or ischemia-induced cardiac dysfunction deteriorated less in PP2A-TG compared to WT. From the data, we conclude that increased PP2A activity may influence the acute stress tolerance of cardiac myocytes.

Keywords: LPS; PP2A; heart; ischemia; protein phosphorylation; sepsis; transgenic mice.

MeSH terms

  • Animals
  • Heart Function Tests
  • Ischemia* / metabolism
  • Lipopolysaccharides / metabolism
  • Mice
  • Myocytes, Cardiac* / metabolism
  • Phosphorylation
  • Protein Phosphatase 2* / genetics
  • Protein Phosphatase 2* / metabolism
  • Protein Processing, Post-Translational
  • Sepsis* / metabolism

Substances

  • Lipopolysaccharides
  • Protein Phosphatase 2